Search

everythinglearnresearchcommunity

for

Search:↓

A woman's total hair loss from hepatitis C treatment grew back after stopping the medication.

High-dose interferon is effective for chronic hepatitis C but often causes flu-like symptoms.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

Lamivudine might reverse hair graying and needs more research for potential treatments.

Some patients may experience temporary total hair loss from hepatitis C treatment with PEG-interferon and ribavirin.

Nirmatrelvir/Ritonavir treatment may lead to a weaker immune response to COVID-19, but doesn't affect the chance of rebound.

Betulinic acid can help treat hepatitis C by stopping virus replication.

Peginterferon alpha-2a effectively treats acute hepatitis C in hemodialysed patients, despite some side effects.

Six African American women experienced hair loss after switching to a new HIV medication.

Pegylated interferon-alpha 2a can cause a rare nerve disorder, but early treatment can lead to full recovery.

Tenofovir is more effective than adefovir for resistant hepatitis B, Fibroscan is good for assessing liver damage, regulatory T cells may help hepatitis C persist, and other insights into liver health and disease were found.

Interferon therapy is a promising and safe treatment for hepatitis B in Southeast Asia.

Peginterferon alfa-2b and ribavirin therapy for hepatitis C can cause serious side effects, some different from those reported in clinical trials.

A woman's psoriasis improved after hepatitis C treatment with interferon, despite interferon's risk of worsening skin conditions.

Some gonadal hormone drugs can block filovirus entry into cells.

HIV can cause various nail and hair disorders, important for early diagnosis and treatment.

Some HIV treatments can harm mitochondria, potentially causing side effects like lactic acidosis and nerve damage.

Stopping antifungal prophylaxis after 1 year may be safe for low-risk transplant patients.

A woman developed white patches on her skin and curly hair after hepatitis C treatment, likely due to the medication interferon alpha.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

Most patients on this hepatitis C treatment experienced skin issues, especially hair loss.

5α-reduced progestogens may reduce mood issues and brain damage linked to HIV-1 Tat.

Zinc supplementation may help improve treatment outcomes for chronic hepatitis C.

A 5-year-old boy's skin condition improved with systemic valganciclovir after a cardiac transplant and immunosuppressive therapy.

Using Favipiravir, a COVID-19 treatment drug, likely doesn't cause hair loss.

A woman lost all her body hair after hepatitis C treatment, but it started to grow back a year after stopping the treatment.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

The document concludes that doctors should monitor children's brain development when treating hemangiomas with interferon alfa and consider stopping the treatment if problems arise, while also exploring drugs that might counteract side effects.

Older age, pre-existing skin conditions, cirrhosis, and pegylated interferon use increase the risk of skin issues during hepatitis C treatment.

A woman with asthma improved from a severe fungal infection after treatment change, and most HIV-positive women in a UK study had low immune cell counts but were responding well to treatment.